Efficacy of MK-0457 and in combination with vorinostat against Philadelphia chromosome positive acute lymphoblastic leukemia cells.
about
Histone acetylation: novel target for the treatment of acute lymphoblastic leukemiaUpdate on aurora kinase inhibitors in gynecologic malignancies.Update on Aurora Kinase Targeted Therapeutics in Oncology.HDAC inhibitors potentiate the activity of the BCR/ABL kinase inhibitor KW-2449 in imatinib-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo.Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: a potential treatment for BCR-ABL-positive leukemiaAurora kinases as druggable targets in pediatric leukemia: heterogeneity in target modulation activities and cytotoxicity by diverse novel therapeutic agents.Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia.Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10).ENMD-2076 for hematological malignancies.JAK2 inhibition for the treatment of hematologic and solid malignancies.Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia.
P2860
Q26778780-C40CFD73-DFD6-4868-86F8-4D4105775EB2Q34576017-5D4FC5BC-210E-4421-AF3D-C8F8566AD065Q34941504-26C3CC21-24C1-4200-B8D7-FFFA8E9E9F24Q34988013-0BE7A243-5EBD-466E-A288-1A90E1E0D7E5Q35106637-36CF56D5-5D9B-4313-9A39-5812580B06A8Q35210664-A12C73CB-D457-4C90-9E5D-BE163F96B28EQ35740894-E5FF1AA0-8614-407B-A218-1459A2476DB4Q37876882-B1D868A9-DDC6-4AA1-BA4A-181D2F994F1AQ37991379-A76EE497-E0A5-4711-82F0-BF95D78CE2AEQ38001733-0781CE88-AAB5-42EF-8516-B97C3C595085Q38141135-E3888493-28DB-45A5-85C7-88268AEA3AAA
P2860
Efficacy of MK-0457 and in combination with vorinostat against Philadelphia chromosome positive acute lymphoblastic leukemia cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Efficacy of MK-0457 and in com ...... lymphoblastic leukemia cells.
@en
Efficacy of MK-0457 and in com ...... lymphoblastic leukemia cells.
@nl
type
label
Efficacy of MK-0457 and in com ...... lymphoblastic leukemia cells.
@en
Efficacy of MK-0457 and in com ...... lymphoblastic leukemia cells.
@nl
prefLabel
Efficacy of MK-0457 and in com ...... lymphoblastic leukemia cells.
@en
Efficacy of MK-0457 and in com ...... lymphoblastic leukemia cells.
@nl
P1433
P1476
Efficacy of MK-0457 and in com ...... lymphoblastic leukemia cells.
@en
P2093
Seiichi Okabe
Tetsuzo Tauchi
P304
P356
10.1007/S00277-010-0998-X
P577
2010-06-20T00:00:00Z